CXCL10 and COVID-19: However, under inflammatory conditions, such as colitis and Crohn’s disease, and infections, like COVID-19, the production of mainly CXCL10 strongly increases, which is associated with high tissue infiltration of activated CXCR3+ T cells (39–43).